AT385656B - METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION, CONTAINING A CYCLIC ERGOT PEPTIDE ALKALOID - Google Patents

METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION, CONTAINING A CYCLIC ERGOT PEPTIDE ALKALOID

Info

Publication number
AT385656B
AT385656B AT0030383A AT30383A AT385656B AT 385656 B AT385656 B AT 385656B AT 0030383 A AT0030383 A AT 0030383A AT 30383 A AT30383 A AT 30383A AT 385656 B AT385656 B AT 385656B
Authority
AT
Austria
Prior art keywords
cyclic
producing
pharmaceutical composition
nasal administration
ergot peptide
Prior art date
Application number
AT0030383A
Other languages
German (de)
Other versions
ATA30383A (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA30383A publication Critical patent/ATA30383A/en
Application granted granted Critical
Publication of AT385656B publication Critical patent/AT385656B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT0030383A 1982-02-01 1983-01-31 METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION, CONTAINING A CYCLIC ERGOT PEPTIDE ALKALOID AT385656B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (2)

Publication Number Publication Date
ATA30383A ATA30383A (en) 1987-10-15
AT385656B true AT385656B (en) 1988-05-10

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0030383A AT385656B (en) 1982-02-01 1983-01-31 METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION, CONTAINING A CYCLIC ERGOT PEPTIDE ALKALOID

Country Status (27)

Country Link
JP (1) JPS58134017A (en)
AT (1) AT385656B (en)
AU (1) AU565613B2 (en)
BE (1) BE895750A (en)
CA (1) CA1197783A (en)
CH (1) CH653555A5 (en)
DE (1) DE3302949A1 (en)
DK (1) DK164771C (en)
ES (1) ES519450A0 (en)
FI (1) FI81258C (en)
FR (1) FR2539994B1 (en)
GR (1) GR81320B (en)
HK (1) HK59989A (en)
HU (1) HU191512B (en)
IE (1) IE54532B1 (en)
IL (1) IL67822A (en)
IT (1) IT1197558B (en)
KE (1) KE3888A (en)
LU (1) LU84613A1 (en)
MY (1) MY8700766A (en)
NL (1) NL192325C (en)
NZ (1) NZ203117A (en)
PH (1) PH22198A (en)
PT (1) PT76166B (en)
SE (1) SE454402B (en)
SG (1) SG34389G (en)
ZA (1) ZA83673B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
JP7317020B2 (en) * 2018-01-05 2023-07-28 インペル ファーマシューティカルズ インコーポレイテッド Intranasal delivery of dihydroergotamine by a precision olfactory device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
AT287186B (en) * 1966-12-22 1971-01-11 Sandoz Ag Process for the production of a new combination preparation of hydrogenated ergot alkaloids
GB1556851A (en) * 1977-04-12 1979-11-28 Roussel Uclaf Pharmaceutical compositions
GB1592563A (en) * 1976-11-19 1981-07-08 Sandoz Ltd Nasal pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2831728C2 (en) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Medicines used to treat headaches

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
AT287186B (en) * 1966-12-22 1971-01-11 Sandoz Ag Process for the production of a new combination preparation of hydrogenated ergot alkaloids
GB1592563A (en) * 1976-11-19 1981-07-08 Sandoz Ltd Nasal pharmaceutical compositions
GB1556851A (en) * 1977-04-12 1979-11-28 Roussel Uclaf Pharmaceutical compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AUSTRIA CODEX 1981 1982, ÖSTERREICHISCHER APOTHEKER-VERLAG, WIEN 1981, S. 153, 152, 969 *
IRAVANI J.; MELVILLE G.N.: RESPIRATION 32, 157-164 (1975) *

Also Published As

Publication number Publication date
IL67822A (en) 1988-02-29
AU1085083A (en) 1983-08-11
MY8700766A (en) 1987-12-31
IT8347646A0 (en) 1983-02-01
NL192325B (en) 1997-02-03
IT1197558B (en) 1988-12-06
FR2539994B1 (en) 1986-10-10
ES8502865A1 (en) 1985-02-01
IL67822A0 (en) 1983-06-15
IE830187L (en) 1983-08-01
ES519450A0 (en) 1985-02-01
PT76166A (en) 1983-02-01
IT8347646A1 (en) 1984-08-01
GR81320B (en) 1984-12-11
SE8300495L (en) 1983-08-02
SE8300495D0 (en) 1983-01-31
IE54532B1 (en) 1989-11-08
NZ203117A (en) 1986-12-05
BE895750A (en) 1983-08-01
FI81258B (en) 1990-06-29
SG34389G (en) 1989-09-22
ATA30383A (en) 1987-10-15
NL192325C (en) 1997-06-04
KE3888A (en) 1989-09-01
CA1197783A (en) 1985-12-10
FI81258C (en) 1990-10-10
DK164771B (en) 1992-08-17
JPH0253406B2 (en) 1990-11-16
NL8300325A (en) 1983-09-01
FR2539994A1 (en) 1984-08-03
HK59989A (en) 1989-08-04
PT76166B (en) 1986-02-04
ZA83673B (en) 1984-09-26
HU191512B (en) 1987-02-27
FI830245A0 (en) 1983-01-25
DK38183A (en) 1983-08-02
CH653555A5 (en) 1986-01-15
SE454402B (en) 1988-05-02
DK164771C (en) 1992-12-28
AU565613B2 (en) 1987-09-24
PH22198A (en) 1988-06-28
JPS58134017A (en) 1983-08-10
FI830245L (en) 1983-08-02
DE3302949C2 (en) 1992-05-21
LU84613A1 (en) 1983-09-08
DE3302949A1 (en) 1983-08-11
DK38183D0 (en) 1983-01-31

Similar Documents

Publication Publication Date Title
AT381638B (en) METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION
ATA377783A (en) METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION
ATA164187A (en) METHOD FOR PRODUCING A PHARMACEUTICAL POWDER
FI881978L (en) Method for preparing a pharmaceutical composition containing eperisone
ATA151687A (en) METHOD FOR PRODUCING A PHARMACEUTICAL CAPSULE FOR THE ORAL ADMINISTRATION OF NITROFURANTOIN (SALTS, HYDRATES, COMPLEXES)
DE3678106D1 (en) METHOD FOR PRODUCING CYCLIC POLYCARBONATOLIGOMERS.
ATA560779A (en) METHOD FOR PRODUCING PHARMACEUTICAL UNIT DOSAGE FORMS
ATA115186A (en) METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION WITH A NON-PROTECTING EFFECT
AT382780B (en) METHOD FOR PRODUCING AN INSULIN SOLUTION
ATA170086A (en) METHOD FOR PRODUCING A SOLID, DURABLE PHARMACEUTICAL FORM
AT385199B (en) METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE
ATA156187A (en) METHOD FOR PRODUCING A SOLID ORAL PHARMACEUTICAL KETOTIFIC COMPOSITION
AT381025B (en) METHOD FOR PRODUCING TOPICAL PHARMACEUTICAL PREPARATIONS
AT365451B (en) METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION CONTAINING ISOSORBIDE DINITRATE
AT382156B (en) METHOD FOR PRODUCING NEW CYCLIC 9'-THIAPEPTIDERGOTAL CALALID
ATA903983A (en) METHOD FOR PRODUCING ANALGETIC AND ANTI-INFLAMMATORY PHARMACEUTICAL PREPARATION
AT388670B (en) METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION WITH A CONTENT OF CALCIUMANTAGONISTS
DE3381345D1 (en) METHOD FOR PRODUCING A COMBINED PHARMACEUTICAL COMPOSITION IN A GRANULAR HETEROGENIC DOSE FORM WITH INCREASED BIOAVAILABILITY.
AT374682B (en) METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION
ATA541377A (en) METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION
ATA30383A (en) METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION, CONTAINING A CYCLIC ERGOT PEPTIDE ALKALOID
AT374365B (en) METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION
ATA92982A (en) METHOD FOR PRODUCING A PHARMACEUTICAL PARENTERAL DOSING UNIT OF NA-PIPERACILLIN
ATA207887A (en) METHOD FOR PRODUCING A PHARMACEUTICAL NICORANDIL PREPARATION FOR PERCUTANIC ABSORPTION
AT383272B (en) METHOD FOR PRODUCING PHARMACEUTICAL TABLETS

Legal Events

Date Code Title Description
ELA Expired due to lapse of time